Martha Lenis

434 total citations
17 papers, 145 citations indexed

About

Martha Lenis is a scholar working on Genetics, Hematology and Neurology. According to data from OpenAlex, Martha Lenis has authored 17 papers receiving a total of 145 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Hematology and 2 papers in Neurology. Recurrent topics in Martha Lenis's work include Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Martha Lenis is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Hemoglobinopathies and Related Disorders (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). Martha Lenis collaborates with scholars based in Canada, Israel and China. Martha Lenis's co-authors include Rena Buckstein, Yulia Lin, Jeannie Callum, Richard A. Wells, Gavin J.B. Elias, Alexandre Boutet, Richard A. Wells, Aaron Loh, Alexandre Mamedov and Kazuaki Yamamoto and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Movement Disorders.

In The Last Decade

Martha Lenis

16 papers receiving 143 citations

Peers

Martha Lenis

HEMAT

NEURO

GENET

CMN

PHYSI

Sara Napolitano Italy

François Jacques Canada

Maria Alberti Spain

Vivien Li Australia

Alessandra Protti Italy

DJ Apple United States

Seyed Mohammad Baghbanian Iran

Claudia Mechi Italy

Serena Mazzotta Italy

Mathula Thangarajh United States

Sara Napolitano Italy

Martha Lenis

61 ×0.9

HEMAT

4 ×0.1

NEURO

47 ×1.1

GENET

20 ×0.6

CMN

33 ×1.3

PHYSI

Citations per year, relative to Martha Lenis Martha Lenis (= 1×) peers Sara Napolitano

Countries citing papers authored by Martha Lenis

Since Specialization

Citations

This map shows the geographic impact of Martha Lenis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Lenis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Lenis more than expected).

Fields of papers citing papers by Martha Lenis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Lenis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Lenis. The network helps show where Martha Lenis may publish in the future.

Co-authorship network of co-authors of Martha Lenis

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Lenis. A scholar is included among the top collaborators of Martha Lenis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Lenis. Martha Lenis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Iorio‐Morin, Christian, Kazuaki Yamamoto, Can Sarica, et al.. (2021). Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST‐FUS Phase 2 Trial). Movement Disorders. 36(11). 2653–2662. 62 indexed citations

Vijenthira, Abi, Jeannie Callum, Yulia Lin, et al.. (2018). The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study. Leukemia Research. 76. 76–81. 11 indexed citations

Vijenthira, Abi, Richard A. Wells, Jeannie Callum, et al.. (2017). Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid. Blood. 130. 1691. 1 indexed citations

Buckstein, Rena, Richard A. Wells, Nancy Zhu, et al.. (2016). Quality of Life Scores Improve with Increasing Hemoglobin but Optimal Thresholds Vary According to Transfusion Dependence and Clinical Risk Scores: A Canadian Cross Sectional Study of 689 Patients with 2969 Measurements. Blood. 128(22). 3192–3192.

Hammond, Danielle, Mina Jamali, Richard A. Wells, et al.. (2016). Impact of Bone Marrow Fibrosis in MDS Patients Treated with Azacitidine. Blood. 128(22). 4339–4339. 3 indexed citations

Lin, Yulia, et al.. (2016). Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion‐dependent patients with myelodysplastic syndromes. Vox Sanguinis. 112(1). 79–86. 32 indexed citations

Parmar, Ambica, Heather A. Leitch, Richard A. Wells, et al.. (2015). Iron Chelation Is Associated with Improved Survival Adjusting for Disease and Patient Related Characteristics in Low/Int-1 Risk MDS at the Time of First Transfusion Dependence: A MDS-CAN Study. Blood. 126(23). 1701–1701. 4 indexed citations

Houston, Brett L., et al.. (2015). 43 A PREDICTIVE MODEL OF RESPONSE TO ERYTHROPOIETIC STIMULATING AGENTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME. Leukemia Research. 39. S19–S20. 1 indexed citations

Buckstein, Rena, Robert S. Kerbel, Matthew C. Cheung, et al.. (2014). Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis. Leukemia Research. 38(7). 756–763. 17 indexed citations

10.

Lin, Yulia, et al.. (2014). Prophylactic Rh and Kell Antigen Matching Significantly Decreases Rates of Alloimmunization in Transfusion Dependent MDS Patients. Blood. 124(21). 4297–4297. 3 indexed citations

11.

Buckstein, Rena, Richard A. Wells, Nancy Zhu, et al.. (2014). Patient Related Factors Have an Indepedent Impact on Overall Survival in Myelodysplastic Syndrome Patients: A Report of the MDS-Can Registry. Blood. 124(21). 165–165. 1 indexed citations

12.

Zhang, Liying, et al.. (2013). Income and outcome in myelodysplastic syndrome: The prognostic impact of SES in a single-payer system. Leukemia Research. 37(11). 1495–1501. 3 indexed citations

13.

Wells, Richard A., et al.. (2012). Validation of the Nordic Scoring System for Erythropoietic Stimulating Agents in MDS Using IWG 2006 Erythroid Response Criteria. Blood. 120(21). 1721–1721. 1 indexed citations

14.

Tseng, Eric, Richard A. Wells, Shabbir M.H. Alibhai, et al.. (2012). The Effects of Azacitidine On Quality of Life: A Prospective Longitudinal Assessment. Blood. 120(21). 4938–4938. 1 indexed citations

15.

Buckstein, Rena, Shabbir M.H. Alibhai, Adam Lam, et al.. (2012). The Independent Effects of Frailty and Comorbidity On the Quality of Life in MDS Patients. Blood. 120(21). 699–699. 1 indexed citations

16.

Fitzgerald, Barbara, et al.. (2005). Why so late? Presentation delay in locally advanced breast cancer (LABC). Journal of Clinical Oncology. 23(16_suppl). 712–712. 3 indexed citations

17.

Dent, R., Barbara Fitzgerald, L. Lickley, et al.. (2005). Do clinical trials of neoadjuvant chemotherapy for locally advanced breast cancer (LABC) overestimate the actual response rates observed in clinical practice?. Journal of Clinical Oncology. 23(16_suppl). 890–890. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact